NCT02209051View on ClinicalTrials.gov

Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Diabetic Foot Ulcers
Interventions
OTHER

AMNIOEXCEL

Application of AMNIOEXCEL every 1-2 weeks for a period of 6 weeks or until wound closure, whichever is sooner.

OTHER

Standard of Care, Diabetic Foot Ulcers

Advanced wound care dressings and offloading applied daily for a period of 8 weeks or until wound closure

Trial Locations (8)

27533

Wayne Memorial Hospital, Goldsboro

27710

Duke University, Durham

32216

First Coast Cardiovascular Institute, Jacksonville

33169

Barry University Clinical Research, North Miami Beach

85015

Associated Foot and Ankle Specialists, LLC, Phoenix

94546

Center for Clinical Research, Inc., Castro Valley

95204

Pacific Wound Center, Stockton

02360

Beth Israel Deaconess Hospital - Plymouth, Plymouth

Sponsors
All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT02209051 - Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter